Prognostic value of 18F-FDG PET/CT SUVmax before R-CHOP treatment for diffuse large B cell lymphoma: an analysis of 76 cases

Prognostic value of 18F-FDG PET/CT SUVmax before R-CHOP treatment for diffuse large B cell lymphoma: an analysis of 76 cases

Objective ;To investigate the survival predictive value of the maximum standard uptake value (SUVmax) of 18F-fluorodeoxy glucose (18F-FDG) in positron emission tomography/computed tomography (PET/CT) in diffuse large B cell lymphoma (DLBCL) patients before R-CHOP treatment. Methods ;The clinical dat...

Full description

Bibliographic Details
Main Authors:	LEI Chengming, WANG Lidan, LI Wenbo, HUANG Ying, DENG Xi
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Third Military Medical University 2020-09-01
Series:	Di-san junyi daxue xuebao
Subjects:	18f-fdg pet/ct suvmax diffuse large b cell lymphoma r-chop treatment kaplan-meier assessment
Online Access:	http://aammt.tmmu.edu.cn/Upload/rhtml/202004326.htm

Similar Items

Beyond lymph nodes: 18F-FDG PET/CT in detection of unusual sites of extranodal lymphoma
by: Amal Ibrahim Ahmed Othman, et al.
Published: (2019-09-01)

Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma
by: Carolin Prexler, et al.
Published: (2022-12-01)

Correlation Between Ki67 Expression and 18F-FDG PET/CT SUVmax in Patient with Diffuse Large B-cell Lymphoma and Their Application in Therapeutic Effect Evaluation
by: YANG Ming, et al.
Published: (2018-12-01)

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma
by: Aino Rajamäki, et al.
Published: (2023-01-01)

A Preliminary Study to Use SUVmax of FDG PET-CT as an Identifier of Lesion for Artificial Intelligence
by: Kenji Hirata, et al.
Published: (2021-04-01)

A novel association between Bmi-1 protein expression and the SUVmax obtained by 18F-FDG PET/CT in patients with gastric adenocarcinoma
by: Guo Ying, et al.
Published: (2022-12-01)

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials
by: Anne-Victoire Michaud-Robert, et al.
Published: (2020-09-01)

Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis
by: Milou C. Schimmelpennink, et al.
Published: (2019-06-01)

Multiple myeloma: characterization of patients through the analysis of semiquantitative parameters with 18F-FDG PET
by: Maria Silvia De Feo, et al.
Published: (2023-06-01)

Is There a Role for [<sup>18</sup>F]FDG PET-CT in Staging MALT Lymphoma?
by: Dan Cohen, et al.
Published: (2022-01-01)

Value of 18F-FDG PET/CT Parameters and Deauville 5-point Scoring in Efficacy Evaluation and Prognosis Prediction of Diffuse Large B Cell Lymphoma Patients
by: YANG Ming, et al.
Published: (2020-08-01)

The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer
by: Gun Oh. Chong, et al.
Published: (2019-02-01)

18F-FDG positron emission tomography in the diagnosis and staging of marginal zone non-Hodgkin lymphomas
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients
by: Magdi A. Ali, et al.
Published: (2023-10-01)

Combined SUVmax and localized colonic wall thickening parameters to identify high-risk lesions from incidental focal colorectal 18F-FDG uptake foci
by: Wenmin Xu, et al.
Published: (2022-08-01)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
by: Vijay Mistry, et al.
Published: (2023-01-01)

Application of 18F-FDG PET-CT Images Based Radiomics in Identifying Vertebral Multiple Myeloma and Bone Metastases
by: Zhicheng Jin, et al.
Published: (2022-04-01)

A Comparative Evaluation of Mediastinal Nodal SUVmax and Derived Ratios from <sup>18</sup>F-FDG PET/CT Imaging to Predict Nodal Metastases in Non-Small Cell Lung Cancer
by: Maha AlRasheedi, et al.
Published: (2023-03-01)

Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
by: Wenbin Yan, et al.
Published: (2023-02-01)

P.67 The Effects of Chemotherapy on Arterial Inflammation Assessed by ¹⁸FDG PET-CT in Patients with Lymphoma
by: Constantinos Anagnostopoulos, et al.
Published: (2020-12-01)

Prognostic prediction by 18F-FDG-PET/CT parameters in patients with neuroblastoma: a systematic review and meta-analysis
by: Ruimin Hu, et al.
Published: (2023-07-01)

Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
by: Tarik Sengoz, et al.
Published: (2023-04-01)

Significance of metabolic parameters and biochemical indexes of 18F-FDG PET/CT in the mid-term evaluation and prognosis of diffuse large B-cell lymphoma
by: Zhang Fan, Zhang Guoxu, Liu Xiuting, Wang Jigang, Liu Yanqin, Tong Danjiang, Liu Jinghua, Zhou Fan
Published: (2022-03-01)

Qualitative and Semiquantitative Parameters of <sup>18</sup>F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule
by: Ferdinando Corica, et al.
Published: (2023-02-01)

The Value of Semiquantitative Parameters Derived from <sup>18</sup>F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer
by: Luca Urso, et al.
Published: (2022-11-01)

Prediction of 2-[<sup>18</sup>F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study
by: Arnaldo Stanzione, et al.
Published: (2023-06-01)

Hybrid imaging of vascular graft infection by positron emission tomography with computed tomography using fluorine-18-labeled fluorodeoxyglucose: The Serbian National PET Center experience
by: Šaponjski Jelena, et al.
Published: (2019-01-01)

Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT
by: Esra Arslan, et al.
Published: (2022-05-01)

Clinical Significance of Incidental 18-FDG Uptake in Nasopharynx on PET/CT Scanning
by: İmdat Yüce, et al.
Published: (2019-11-01)

Use of F-18 FDG PET/CT Through Delayed Diuretic Imaging for Preoperative Evaluation of Upper Urinary Tract-Occupying Lesions
by: Jun Wang, et al.
Published: (2021-08-01)

FDG-PET in mantle cell lymphoma involving skin
by: Mehmet Sönmez, et al.
Published: (2010-12-01)

Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
by: Melikşah Bayar, et al.
Published: (2021-05-01)

Prognostic factors associated with 18FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
by: Wei-Hsiang Feng, et al.
Published: (2022-07-01)

Clinical value of 18F-FDG PET/CT in the management of HIV-associated lymphoma
by: Qi Liu, et al.
Published: (2023-01-01)

Clinical features and 18F-FDG PET/CT for distinguishing of malignant lymphoma from inflammatory lymphadenopathy in HIV-infected patients
by: Donghe Chen, et al.
Published: (2022-07-01)

Differentiation of soft tissue and bone sarcomas from benign lesions utilizing 18F-FDG PET/CT-derived parameters
by: Bo Chen, et al.
Published: (2020-07-01)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
by: Yassine Al Tabaa, et al.
Published: (2021-10-01)

Assessment of treatment response in cardiac sarcoidosis based on myocardial 18F-FDG uptake
by: Lukas Frischknecht, et al.
Published: (2023-11-01)

The role of 18F-FDG PET/CT in evaluation of Primary CNS lymphoma: The path less travelled
by: Sharjeel Usmani, et al.
Published: (2023-07-01)

Follicular lymphoma presenting as a seminal vesicle mass: Diagnostic path from prostate MRI to 18F-FDG PET/CT
by: Burcin Agridag Ucpinar, MD, et al.
Published: (2023-08-01)